Price movement over the last 24 hours
Agilent Technologies Inc vs Flagstar Bank NA — how do they compare? Agilent Technologies Inc trades at $129.02 (market cap $37.04B), while Flagstar Bank NA trades at $14.47 (market cap $6.15B). The key difference: Agilent Technologies Inc is far larger — about 6× Flagstar Bank NA's market cap, and Agilent Technologies Inc pays the higher dividend (0.78%). Which is the better fit depends on your goals.
| A | FLG | |
|---|---|---|
Market Cap | $37.04B | $6.15B |
Sector | Health | Financials |
52-Week High | $157.20 | $15.28 |
52-Week Low | $110.24 | $10.72 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | 0.27% |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Flagstar Bank (FLG) trades at $14.84, up 1.71% today, showing technical bullish momentum with strong moving average signals. The company has delivered two consecutive quarterly earnings beats (Q4 2025 and Q1 2026) and recently announced a proprietary technology transformation. Despite negative profitability metrics, the stock trades below book value (P/B 0.81) and analysts maintain a 50/50 buy/hold split with a $16.94 consensus target.
FLG presents a turnaround story with improving fundamentals but carries execution risks. The bank's shift toward profitability and technology investments offers potential upside, though negative margins and high interest expenses remain concerns. With the current price below analyst targets, the stock offers value potential but requires careful monitoring of credit quality and operational improvements.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →Flagstar Bank is a prominent US financial institution and a subsidiary of New York Community Bancorp. It provides commercial banking, mortgage services, and diverse personal finance products.
Read more on FLG →